Enteric fever: Difference between revisions

From IDWiki
No edit summary
(added doses)
 
(2 intermediate revisions by the same user not shown)
Line 2: Line 2:
 
===Microbiology===
 
===Microbiology===
   
*Caused by ''[[Salmonella enterica]]'' subsp. ''typii'' and ''paratyphii''
+
*Caused by ''[[Salmonella enterica]]'' subspecies ''enterica'' serotypes Typhi and Paratyphi
 
*Virulence is related to Vi antigen and invasin protein
 
*Virulence is related to Vi antigen and invasin protein
   
Line 12: Line 12:
 
===Pathophysiology===
 
===Pathophysiology===
   
*Induction of pH-shock proteins and other adaptions allow ingested bacteria to pass through the stomch and into the small intestine
+
*Induction of pH-shock proteins and other adaptions allow ingested bacteria to pass through the stomach and into the small intestine
*There, they penetrate the intestinal mucosa followed by mononuclear cells, which transport them to lypmh nodes
+
*There, they penetrate the intestinal mucosa followed by mononuclear cells, which transport them to lymph nodes
 
*They multiple within the reticuloendothelial system during the incubation period
 
*They multiple within the reticuloendothelial system during the incubation period
 
*After a threshold is reached, they disseminate to blood
 
*After a threshold is reached, they disseminate to blood
Line 30: Line 30:
 
**[[Myelitis]], [[psychosis]], [[ataxia]], [[parkinsonism]]
 
**[[Myelitis]], [[psychosis]], [[ataxia]], [[parkinsonism]]
 
**[[Meningoencephalopathy]]
 
**[[Meningoencephalopathy]]
**[[abscess]] or [[empyema]]
+
**[[Abscess]] or [[empyema]]
 
**[[Endocarditis]], [[myocarditis]], and [[pericarditis]]
 
**[[Endocarditis]], [[myocarditis]], and [[pericarditis]]
 
**[[Pneumonia]]
 
**[[Pneumonia]]
Line 38: Line 38:
 
==Diagnosis==
 
==Diagnosis==
   
*Blood cultures (large volume, like x4), stool cultures, bone marrow
+
*Blood cultures (large volume, like x4), stool cultures, bone marrow biopsy (most sensitive)
*Biopsy (most sensitive)
 
   
 
==Management==
 
==Management==
Line 45: Line 44:
 
*Treatment with third-generation cephalosporins like [[Is treated by::ceftriaxone]], stepped down to oral when improving and susceptibility data are available
 
*Treatment with third-generation cephalosporins like [[Is treated by::ceftriaxone]], stepped down to oral when improving and susceptibility data are available
 
**Alternatives are [[Is treated by::azithromycin]], followed by [[ampicillin]], [[TMP-SMX]], [[chloramphenicol]]
 
**Alternatives are [[Is treated by::azithromycin]], followed by [[ampicillin]], [[TMP-SMX]], [[chloramphenicol]]
**Avoid fluoroquinolones due to high resistance rate
+
**Avoid [[fluoroquinolones]] due to high resistance rate
 
*Duration 10 to 14 days
 
*Duration 10 to 14 days
 
**Can take 4 to 6 days to defervesce, even with treatment
 
**Can take 4 to 6 days to defervesce, even with treatment
 
*Monitor for relapse 2 to 3 weeks after treatment ends
 
*Monitor for relapse 2 to 3 weeks after treatment ends
  +
{| class="wikitable"
 
  +
!Antibiotic
  +
!Dose
  +
!Duration
  +
|-
  +
|[[azithromycin]]
  +
|1 g p.o. once followed by 500 mg p.o. daily, or
  +
1 g p.o. daily
  +
|5 to 7 days
  +
|-
  +
|[[ciprofloxacin]]
  +
|500 mg p.o. twice daily
  +
| rowspan="2" |7 to 10 days
  +
|-
  +
|[[ofloxacin]]
  +
|400 mg p.o. twice daily
  +
|-
  +
|[[ceftriaxone]]
  +
|2 g IV daily
  +
| rowspan="6" |10 to 14 days
  +
|-
  +
|[[cefotaxime]]
  +
|1 to 2 g IV every 6 to 8 hours
  +
|-
  +
|[[cefixime]]
  +
|200 mg p.o. twice daily
  +
|-
  +
|[[meropenem]]
  +
|1 to 2 IV every 8 hours
  +
|-
  +
|[[TMP-SMX]]
  +
|1 DS tablet p.o. twice daily
  +
|-
  +
|[[amoxicillin]]
  +
|1 g p.o. three times daily
  +
|-
  +
|[[chlormaphenicol]]
  +
|500 tp 750 mg p.o. four times daily
  +
|14 to 21 days
  +
|}
 
[[Category:Gram-negative bacilli]]
 
[[Category:Gram-negative bacilli]]
 
[[Category:Returned travellers]]
 
[[Category:Returned travellers]]

Latest revision as of 10:59, 13 May 2024

Background

Microbiology

  • Caused by Salmonella enterica subspecies enterica serotypes Typhi and Paratyphi
  • Virulence is related to Vi antigen and invasin protein

Epidemiology

  • Fecal-oral transmission acquired from contaminated food, milk, or water
  • Less than 5% of infected people become chronic carriers, with bacteria remaining in the gallbladder despite adequate antibiotic treatment

Pathophysiology

  • Induction of pH-shock proteins and other adaptions allow ingested bacteria to pass through the stomach and into the small intestine
  • There, they penetrate the intestinal mucosa followed by mononuclear cells, which transport them to lymph nodes
  • They multiple within the reticuloendothelial system during the incubation period
  • After a threshold is reached, they disseminate to blood

Clinical Manifestations

Diagnosis

  • Blood cultures (large volume, like x4), stool cultures, bone marrow biopsy (most sensitive)

Management

  • Treatment with third-generation cephalosporins like ceftriaxone, stepped down to oral when improving and susceptibility data are available
  • Duration 10 to 14 days
    • Can take 4 to 6 days to defervesce, even with treatment
  • Monitor for relapse 2 to 3 weeks after treatment ends
Antibiotic Dose Duration
azithromycin 1 g p.o. once followed by 500 mg p.o. daily, or

1 g p.o. daily

5 to 7 days
ciprofloxacin 500 mg p.o. twice daily 7 to 10 days
ofloxacin 400 mg p.o. twice daily
ceftriaxone 2 g IV daily 10 to 14 days
cefotaxime 1 to 2 g IV every 6 to 8 hours
cefixime 200 mg p.o. twice daily
meropenem 1 to 2 IV every 8 hours
TMP-SMX 1 DS tablet p.o. twice daily
amoxicillin 1 g p.o. three times daily
chlormaphenicol 500 tp 750 mg p.o. four times daily 14 to 21 days